Current Problems with Value Assessments and Ideas for Improvement

In an op-ed published by Fierce Healthcare, Director of Scientific Communications, Mark Linthicum discusses current shortfalls of value assessment and what is needed to move to value assessment 2.0. Read the full article here.

2018-07-11T14:10:32+00:00July 11th, 2018|Viewpoints|

An Open-Source Approach Will Drive Healthcare Value Assessment 2.0

Measuring value in healthcare, which frequently takes the perspective of a single payer managing population health and costs, needs to evolve to include diverse perspectives and provide relevant and actionable information on value to healthcare decision makers, according to a new article written by IVI’s Mark Linthicum, Jennifer Bright and Jason Shafrin and published [...]

2018-06-20T14:17:02+00:00June 14th, 2018|IVI News, Press, Viewpoints|

Patient-Centered Formularies: Steps in the Right Direction, but Challenges Remain

In a post on the IVI-sponsored Health Affairs featured blog series, Drugs and Medical Innovation, Jason Shafrin (IVI Director of Research) and Mark Linthicum (IVI Director of Scientific Communications) explore the role that formularies play in determining value for different stakeholders, and how unique, multi-stakeholder efforts can make formularies more patient-centered. Read the full article [...]

2018-04-16T12:22:51+00:00April 11th, 2018|Viewpoints|

Using Outcomes-Based Pricing for Medical Devices to Improve Cardiovascular Disease Treatment Value

In a post on the IVI-sponsored Health Affairs featured blog series Drugs and Medical Innovation, Daniel Blumenthal, Samuel Nussbaum (IVI Strategic Advisory Panel Chair), Mark Linthicum (IVI Director of Scientific Communications), and Neil Weissman (IVI Strategic Advisory Panel member) explore how outcomes-based pricing agreements (OBAs) could be utilized for medical devices used to treat cardiovascular [...]

2018-03-30T18:04:16+00:00March 29th, 2018|Viewpoints|

To Get Our Money’s Worth in Healthcare, We Need to Collaborate

In a commentary for Modern Healthcare, IVI Director of Scientific Communications, Mark Linthicum, emphasizes that the healthcare system needs to embrace collaboration to find consensus in the way we measure and pay for health care value. Read the full article here.

2018-01-22T22:29:16+00:00January 22nd, 2018|Viewpoints|

Well-Informed Patients Play a Key Role in Value-Based Care

In a commentary for Morning Consult, Virginia Ladd, President and Executive Director of the American Autoimmune Related Diseases Association (AARDA), emphasizes how critical it is that the patient perspective be front and center in discussions about how we measure and pay for value. Read the full article here.

2018-01-18T05:19:24+00:00January 12th, 2018|Viewpoints|

Putting More Value Into Biopharmaceutical Value Assessments

In a commentary for the Health Affairs Blog, Rena M. Conti, PhD, and IVI Executive Director, Darius Lakdawalla, argue that advancing the science of value assessment requires new assessment tools that are transparent and incorporate the perspectives of patients and insurance plan enrollees. Read the full article here.

2018-02-23T20:39:07+00:00January 4th, 2018|Viewpoints|

An Open-Source Consensus-Based Approach to Value Assessment

In a commentary for the Health Affairs Blog, IVI's Jeroen Jansen, Devin Incerti, and Mark Linthicum argue that, in order to move toward consensus on value assessment, the process for defining and measuring value must be transparent, collaborative, and iterative. IVI is taking the first steps towards consensus with the development of the Open-Source Value Project. [...]

2017-12-15T23:12:42+00:00December 15th, 2017|Viewpoints|

IVI’s Mark Linthicum in Morning Consult: Why Understanding Value is Central to True Health Care Reform

Mark Linthicum makes the case that value-based spending should be the focus of health care reform efforts in Washington, D.C. On September 13th health care stakeholders came together at the National Press Club to discuss better approaches to measuring value. Read Full Article Here

2017-11-11T01:18:31+00:00September 20th, 2017|Viewpoints|

Shafrin Defines Precision Medicine for U.S. News and World Report

In a new commentary for U.S. News and World Report, Jason Shafrin defines and elaborates on the field of precision medicine. Jason, IVI's Director of Research, illustrates how the United States is moving headlong into this new treatment approach. He notes some of the challenges while also emphasizing the unique hope precision medicine brings through [...]

2017-11-11T01:22:04+00:00August 25th, 2017|Viewpoints|